TY - JOUR
T1 - Predicting the phenotype of Pompe Disease from features of GAA variants
AU - Rajamani, Geetanjali
AU - Pillai, Nishitha R.
AU - Stafki, Seth A
AU - Karachunski, Peter I.
AU - Kang, Peter B
N1 - Publisher Copyright:
© The Author(s), under exclusive licence to European Society of Human Genetics 2025.
PY - 2025
Y1 - 2025
N2 - As the management of Pompe disease depends on whether an individual has infantile onset Pompe disease (IOPD) or late onset Pompe disease (LOPD), the question of whether the phenotype can be predicted from specific pathogenic variants is becoming increasingly important. We reviewed published cases of Pompe disease in which IOPD versus LOPD and pathogenic GAA variants were assigned for specific individuals. We then compared variant types and locations versus phenotypes. We identified 115 cases, 42 with IOPD and 73 with LOPD. We found that two features of GAA variants can help predict phenotype: (1) presence of a splice variant on at least one allele and (2) location in specific protein domains. These findings help provide prognoses for newborns diagnosed with Pompe disease. Our analysis will also help expecting and prospective parents who pursue genetic testing as they consider therapeutic options that may be beneficial to implement soon after birth.
AB - As the management of Pompe disease depends on whether an individual has infantile onset Pompe disease (IOPD) or late onset Pompe disease (LOPD), the question of whether the phenotype can be predicted from specific pathogenic variants is becoming increasingly important. We reviewed published cases of Pompe disease in which IOPD versus LOPD and pathogenic GAA variants were assigned for specific individuals. We then compared variant types and locations versus phenotypes. We identified 115 cases, 42 with IOPD and 73 with LOPD. We found that two features of GAA variants can help predict phenotype: (1) presence of a splice variant on at least one allele and (2) location in specific protein domains. These findings help provide prognoses for newborns diagnosed with Pompe disease. Our analysis will also help expecting and prospective parents who pursue genetic testing as they consider therapeutic options that may be beneficial to implement soon after birth.
UR - http://www.scopus.com/inward/record.url?scp=85214238471&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85214238471&partnerID=8YFLogxK
U2 - 10.1038/s41431-024-01771-z
DO - 10.1038/s41431-024-01771-z
M3 - Article
C2 - 39775060
AN - SCOPUS:85214238471
SN - 1018-4813
JO - European Journal of Human Genetics
JF - European Journal of Human Genetics
M1 - 1111
ER -